A journal formerly published by Hindawi has yet to publish any sort of notice on a paper sleuths reported for containing duplicated images 1.5 years ago. The article, "Resveratrol Derivative, Trans-3, 5, 4 ′-Trimethoxystilbene Sensitizes Osteosarcoma Cells to Apoptosis via ROS-Induced Caspases Activation", appeared in Oxidative Medicine and Cellular Longevity in 2021. Clarivate removed the journal from its Web of Science index in March 2023 for failing to meet quality criteria.

In April 2023, Elisabeth Bik left a comment on PubPeer, noting "several figures in this paper look identical to figures in a 2019 paper by some of the same authors", which had been retracted. "I could not find wording about e.g. a republication of part of that study, and the 2019 paper is not included in the references", she wrote.

Although Wiley (which Hindawi purchased) "has been aware of multiple serious problems in this paper" for more than 18 months, the publisher has not marked it with an expression of concern or any other indication of the ongoing investigation.

Source: https://retractionwatch.com/2024/12/11/19-months-and-counting-former-hindawi-journal-still-hasnt-marked-paper/